Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study [Peripheral Vascular Disease]
Conclusions—
DA+DCB treatment was effective and safe, but the study was not powered to show significant differences between the 2 methods of revascularization in 1-year follow-up. An adequately powered randomized trial is warranted.
Clinical Trial Registration—
http://www.clinicaltrials.gov. Unique Identifier: NCT01366482.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Zeller, T., Langhoff, R., Rocha-Singh, K. J., Jaff, M. R., Blessing, E., Amann-Vesti, B., Krzanowski, M., Peeters, P., Scheinert, D., Torsello, G., Sixt, S., Tepe, G., on behalf of the DEFINITIVE AR Investigators Tags: Revascularization, Quality and Outcomes, Peripheral Vascular Disease, Stenosis, Vascular Disease Source Type: research
More News: Angiography | Cardiology | Cardiovascular | Clinical Trials | Heart | Intermittent Claudication | Pain | Peripheral Vascular Disease (PVD) | Study | Ultrasound